Literature DB >> 29564739

Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.

Ratneev Kaur1, Tajinder Kaur2, Anupam Kaur3.   

Abstract

PURPOSE: Polycystic ovary syndrome (PCOS) is a complex multifactorial endocrine disorder affecting approximately 5-10% of women of reproductive age. Affected women have menstrual disturbances due to anovulation, infertility, and hyperandrogenism. Ovarian androgen overproduction is the key physiopathologic feature of PCOS. A number of genes encoding major enzymes of the androgen metabolic pathways, such as HSD17B6, CYP19A1, CYP11A1, CYP17A1, and INSR, have been examined. Very few studies have been done in North India. There is an increasing prevalence of PCOS in women in Punjab and it is the leading cause of female infertility. In view of the strong evidence implicating the importance of CYP19A1 and CYP17A1 in androgen metabolic pathways, we investigated the association of rs700519, rs2414096, and rs743572 (- 34T>C) polymorphisms on susceptibility of developing PCOS, in North India.
METHODS: A total of 500 subjects (women of reproductive age) including 250 PCOS cases and 250 healthy age-matched controls were included in the present study. DNA was extracted from venous blood for all samples, and association analysis for rs2414096, rs700519, and rs743572 was done by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. Lipid profile was done using a biochemical analyzer and body mass index (BMI) was measured for all cases. Statistical analysis was performed.
RESULTS: Significant association of - 34T>C polymorphism of CYP17A1 was found with PCOS (p = 0.0005). BMI was statistically different between PCOS cases and controls (p = 0.000). Triglycerides were high in PCOS women. Variations of CYP19A1 were not statistically significant with PCOS.
CONCLUSIONS: These data suggest that - 34T>C polymorphism in CYP17A1 is associated with PCOS in North India. No polymorphism of CYP19A1 was found to be associated.

Entities:  

Keywords:  BMI; CYP17A1; CYP19A1; Lipid profile; Polycystic ovary syndrome; Polymorphism

Mesh:

Substances:

Year:  2018        PMID: 29564739      PMCID: PMC6030014          DOI: 10.1007/s10815-018-1162-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  43 in total

Review 1.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.

Authors: 
Journal:  Lancet       Date:  2004-01-10       Impact factor: 79.321

2.  Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry.

Authors:  Tord Naessen; Mark M Kushnir; Andrey Chaika; Jelena Nosenko; Iryna Mogilevkina; Alan L Rockwood; Kjell Carlstrom; Jonas Bergquist; Dmitrijus Kirilovas
Journal:  Fertil Steril       Date:  2010-02-19       Impact factor: 7.329

3.  Ovarian enzyme activities in women with polycystic ovary syndrome.

Authors:  Denis A Magoffin
Journal:  Fertil Steril       Date:  2006-07       Impact factor: 7.329

Review 4.  Impact of obesity on infertility in women.

Authors:  Zeynep Özcan Dağ; Berna Dilbaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

5.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

Authors:  M Urbanek; R S Legro; D A Driscoll; R Azziz; D A Ehrmann; R J Norman; J F Strauss; R S Spielman; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Polymorphism T-->C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome.

Authors:  E Diamanti-Kandarakis; M I Bartzis; E D Zapanti; G G Spina; F A Filandra; T C Tsianateli; A T Bergiele; C R Kouli
Journal:  Fertil Steril       Date:  1999-03       Impact factor: 7.329

7.  Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.

Authors:  Melissa Kahsar-Miller; Larry R Boots; Alfred Bartolucci; Ricardo Azziz
Journal:  Fertil Steril       Date:  2004-10       Impact factor: 7.329

8.  CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.

Authors:  Nectaria Xita; Leandros Lazaros; Ioannis Georgiou; Agathocles Tsatsoulis
Journal:  Fertil Steril       Date:  2009-03-26       Impact factor: 7.329

9.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

Authors:  R S Legro; A R Kunselman; W C Dodson; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

10.  The relationship between the CYP19 alleles rs727479A/C, rs700518A/G, and rs700519C/T and pregnancy outcome after assisted reproductive technology in patients with polycystic ovary syndrome in a Chinese population: A population-based study.

Authors:  Qian Dou; Li Tan; Li-Ying Ma; Ying-Pu Sun
Journal:  Kaohsiung J Med Sci       Date:  2017-07-14       Impact factor: 2.744

View more
  8 in total

1.  The role of DENND1A and CYP19A1 gene variants in individual susceptibility to obesity in Turkish population-a preliminary study.

Authors:  Ela Kadioglu; Beril Altun; Çağrı İpek; Esra Döğer; Aysun Bideci; Hadi Attaran; İsmet Çok
Journal:  Mol Biol Rep       Date:  2018-09-19       Impact factor: 2.316

Review 2.  A Review on CYP11A1, CYP17A1, and CYP19A1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (PCOS) and Infertility.

Authors:  Roozbeh Heidarzadehpilehrood; Maryam Pirhoushiaran; Rasoul Abdollahzadeh; Malina Binti Osman; Maryam Sakinah; Norshariza Nordin; Habibah Abdul Hamid
Journal:  Genes (Basel)       Date:  2022-02-05       Impact factor: 4.096

3.  The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis.

Authors:  Chuan Xing; Han Zhao; Jiaqi Zhang; Bing He
Journal:  Front Physiol       Date:  2022-05-09       Impact factor: 4.755

4.  Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway in vivo.

Authors:  Jie Zhou; Yong Tan; Xudong Wang; Meihong Zhu
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

Review 5.  CYP17 T/C (rs74357) gene polymorphism contributes to polycystic ovary syndrome susceptibility: evidence from a meta-analysis.

Authors:  Xingyan Liu; Mei Xu; Min Qian; Lindong Yang
Journal:  Endocr Connect       Date:  2021-12-07       Impact factor: 3.335

Review 6.  An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.

Authors:  Hiya Islam; Jaasia Masud; Yushe Nazrul Islam; Fahim Kabir Monjurul Haque
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

7.  Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women.

Authors:  Sairish Ashraf; Shayaq Ul Abeer Rasool; Mudasar Nabi; Mohd Ashraf Ganie; Shariq R Masoodi; Shajrul Amin
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

Review 8.  Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.

Authors:  Nahid Sarahian; Hosna Sarvazad; Elham Sajadi; Nasrin Rahnejat; Narges Eskandari Roozbahani
Journal:  Reprod Health       Date:  2021-07-26       Impact factor: 3.223

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.